Head-to-head · WeighScore
Hers vs RxSpan MD
The verdict
RxSpan MD takes it — 84.3/100 to 60.7/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD offers compounded injections, oral options and a brand-name lane, with regular monthly pricing alongside discounted prepaid plans that require a closer look at renewal and refund terms.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Hers | RxSpan MD |
|---|---|---|
| WeighScore | 60.7/100 | 84.3/100 |
| Grade | C | B |
| Site position | #359 | #5 |
| Semaglutide | From $149/mo (Wegovy pill; plus required care: $39 first month, then $149/mo) | $249/mo month-to-month ($219 on three months, $199 on six, $194 on twelve) |
| Tirzepatide | From $299/mo (Zepbound vial or KwikPen; plus required care: $39 first month, then $149/mo) | $329/mo month-to-month ($309 on three months, $289 on six, $269 on twelve) |
| Coverage | Not available in every state; confirm eligibility | Confirm treatment availability during intake |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #359 · C
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.
Strengths
- Branded Wegovy pill and pen, plus Zepbound vial or KwikPen options listed
- Ongoing provider messaging and monthly care-team follow-ups described
- Published membership and medication charges can be compared separately
What to consider
- Required care membership is $39 first month, then $149 monthly, extra to medication
- Membership and medication cancellation are separate; shipped prepaid supply may keep membership charges payable
- Availability and medication prices depend on state, product, dose and plan
- FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025 concerning compounded-semaglutide promotion; this is distinct from current branded-product approval
Site position #5 · B
Strengths
- Public catalog offers compounded injections, oral options and brand-name programs
- Regular monthly injection pricing of $249 semaglutide and $329 tirzepatide
- Catalog states consultation, medication, supplies, shipping and support are included
- Names physician founder Dr. John Diaz and describes licensed-physician review
What to consider
- Lowest advertised monthly equivalents require prepaid terms and a promotional code
- Annual promotions automatically renew
- Public terms do not establish a refund schedule for unused prepaid treatment
- Compounded semaglutide and tirzepatide are not FDA-approved
Featured provider
RxSpan MD
RxSpan MD scores 84.3/100 (B). RxSpan MD offers compounded injections, oral options and a brand-name lane, with regular monthly pricing alongside discounted prepaid plans that require a closer look at renewal and refund terms.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.